Birdwatch Note
2024-03-07 12:51:51 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
帯状疱疹の患者数は多数の国地域でモニタリングされており日本を含め各先進国でコロナ禍前より減少しています。 出典 日本の宮崎スタディが↓の2つめの図 https://web.archive.org/web/20230725185950/https://news.yahoo.co.jp/articles/6ca1c6739b46d8201f28467a56bfd773cc2332af 豪州は以下のページのdisease name:varicella zoster (shingles)です https://nindss.health.gov.au/pbi-dashboard/ 英国が↓にまとめ https://twitter.com/covidacc/status/1710136643670475132/photo/2 元データがこちら↓ https://www.gov.uk/government/publications/gp-in-hours-weekly-bulletins-for-2022 接種者や接種直後に微妙な客観的医療記録の増加があるかはそれが確認された研究も https://www.nejm.org/doi/full/10.1056/nejmoa2110475 確認されなかった研究も https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2798504 存在します。 が、いずれにせよ帯状疱疹患者数は1つの要因で決まる訳ではなく総合すると上記各高接種先進国で患者が減少した形になっています。
Written by F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1765701369472995732
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1765722027904958927
- noteId - 1765722027904958927
- participantId -
- noteAuthorParticipantId - F4D2E4CA66E08B99BDDE8328BBF4C2313B853B3595C8AC38600E463328C72D9D Participant Details
- createdAtMillis - 1709815911639
- tweetId - 1765701369472995732
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 帯状疱疹の患者数は多数の国地域でモニタリングされており日本を含め各先進国でコロナ禍前より減少しています。 出典 日本の宮崎スタディが↓の2つめの図 https://web.archive.org/web/20230725185950/https://news.yahoo.co.jp/articles/6ca1c6739b46d8201f28467a56bfd773cc2332af 豪州は以下のページのdisease name:varicella zoster (shingles)です https://nindss.health.gov.au/pbi-dashboard/ 英国が↓にまとめ https://twitter.com/covidacc/status/1710136643670475132/photo/2 元データがこちら↓ https://www.gov.uk/government/publications/gp-in-hours-weekly-bulletins-for-2022 接種者や接種直後に微妙な客観的医療記録の増加があるかはそれが確認された研究も https://www.nejm.org/doi/full/10.1056/nejmoa2110475 確認されなかった研究も https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2798504 存在します。 が、いずれにせよ帯状疱疹患者数は1つの要因で決まる訳ではなく総合すると上記各高接種先進国で患者が減少した形になっています。
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-03-07 12:51:51 UTC (1709815911639) |
2024-03-08 01:20:26 UTC (1709860826938) |
CURRENTLY_RATED_HELPFUL | 2024-03-08 01:20:26 UTC (1709860826938) |
CURRENTLY_RATED_HELPFUL | 2024-03-08 01:20:26 UTC (1709860826938) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-03-07 07:30:56 -0600 | Rating Details | |
| 2024-03-07 07:30:22 -0600 | Rating Details | |
| 2024-03-07 07:24:34 -0600 | Rating Details | |
| 2024-03-07 07:23:34 -0600 | Rating Details | |
| 2024-03-07 07:20:09 -0600 | Rating Details | |
| 2024-03-07 07:19:25 -0600 | Rating Details | |
| 2024-03-07 07:18:21 -0600 | Rating Details | |
| 2024-03-07 07:02:00 -0600 | Rating Details | |
| 2024-03-07 16:52:00 -0600 | Rating Details | |
| 2024-03-07 16:18:38 -0600 | Rating Details | |
| 2024-03-07 15:48:09 -0600 | Rating Details | |
| 2024-03-07 14:40:12 -0600 | Rating Details | |
| 2024-03-07 13:14:42 -0600 | Rating Details | |
| 2024-03-07 11:27:14 -0600 | Rating Details | |
| 2024-03-07 10:00:37 -0600 | Rating Details | |
| 2024-03-07 09:46:58 -0600 | Rating Details | |
| 2024-03-07 09:25:32 -0600 | Rating Details | |
| 2024-03-07 08:59:09 -0600 | Rating Details | |
| 2024-03-07 08:48:29 -0600 | Rating Details | |
| 2024-03-07 08:22:10 -0600 | Rating Details | |
| 2024-03-07 08:16:37 -0600 | Rating Details | |
| 2024-03-07 08:04:59 -0600 | Rating Details | |
| 2024-03-07 07:36:45 -0600 | Rating Details | |
| 2024-03-07 07:35:22 -0600 | Rating Details | |
| 2024-03-07 07:33:24 -0600 | Rating Details | |
| 2024-03-08 02:20:21 -0600 | Rating Details | |
| 2024-03-08 00:45:16 -0600 | Rating Details | |
| 2024-03-08 02:51:56 -0600 | Rating Details | |
| 2024-03-07 23:07:10 -0600 | Rating Details | |
| 2024-03-07 22:33:52 -0600 | Rating Details | |
| 2024-03-07 21:49:34 -0600 | Rating Details | |
| 2024-03-07 17:35:51 -0600 | Rating Details | |
| 2024-03-07 17:02:32 -0600 | Rating Details | |
| 2024-03-07 16:50:19 -0600 | Rating Details | |
| 2024-03-07 16:26:23 -0600 | Rating Details | |
| 2024-03-07 15:36:35 -0600 | Rating Details | |
| 2024-03-07 15:29:23 -0600 | Rating Details | |
| 2024-03-07 15:28:15 -0600 | Rating Details | |
| 2024-03-07 15:04:05 -0600 | Rating Details | |
| 2024-03-07 14:33:00 -0600 | Rating Details | |
| 2024-03-07 13:11:24 -0600 | Rating Details | |
| 2024-03-07 12:59:02 -0600 | Rating Details | |
| 2024-03-07 11:47:13 -0600 | Rating Details | |
| 2024-03-07 11:31:21 -0600 | Rating Details | |
| 2024-03-07 11:11:01 -0600 | Rating Details | |
| 2024-03-07 10:02:39 -0600 | Rating Details | |
| 2024-03-07 09:50:10 -0600 | Rating Details | |
| 2024-03-07 09:22:07 -0600 | Rating Details | |
| 2024-03-07 08:44:29 -0600 | Rating Details | |
| 2024-03-07 08:36:52 -0600 | Rating Details | |
| 2024-03-07 08:21:24 -0600 | Rating Details | |
| 2024-03-07 07:51:54 -0600 | Rating Details | |
| 2024-03-07 07:48:50 -0600 | Rating Details | |
| 2024-03-07 07:33:13 -0600 | Rating Details | |
| 2024-03-07 07:21:57 -0600 | Rating Details | |
| 2024-03-07 07:21:05 -0600 | Rating Details | |
| 2024-03-07 07:09:45 -0600 | Rating Details | |
| 2024-03-07 07:09:45 -0600 | Rating Details | |
| 2024-03-07 07:01:28 -0600 | Rating Details | |
| 2024-03-09 09:16:06 -0600 | Rating Details | |
| 2024-03-08 20:40:47 -0600 | Rating Details | |
| 2024-03-08 07:26:03 -0600 | Rating Details | |
| 2024-03-07 20:25:26 -0600 | Rating Details | |
| 2024-03-07 19:52:32 -0600 | Rating Details | |
| 2024-03-07 18:47:31 -0600 | Rating Details | |
| 2024-03-07 15:56:29 -0600 | Rating Details | |
| 2024-03-07 14:24:25 -0600 | Rating Details | |
| 2024-03-07 12:58:57 -0600 | Rating Details | |
| 2024-03-07 10:50:14 -0600 | Rating Details | |
| 2024-03-07 09:32:44 -0600 | Rating Details | |
| 2024-03-07 09:25:52 -0600 | Rating Details | |
| 2024-03-07 09:22:57 -0600 | Rating Details | |
| 2024-03-07 09:14:07 -0600 | Rating Details | |
| 2024-03-07 09:07:51 -0600 | Rating Details | |
| 2024-03-07 08:41:10 -0600 | Rating Details | |
| 2024-03-07 08:38:22 -0600 | Rating Details | |
| 2024-03-07 08:03:09 -0600 | Rating Details | |
| 2024-03-07 07:59:59 -0600 | Rating Details | |
| 2024-03-07 07:42:27 -0600 | Rating Details | |
| 2024-03-07 07:28:23 -0600 | Rating Details | |
| 2024-03-07 07:16:56 -0600 | Rating Details | |
| 2024-03-07 07:12:43 -0600 | Rating Details | |
| 2024-03-07 07:11:28 -0600 | Rating Details | |
| 2024-03-07 06:54:53 -0600 | Rating Details | |
| 2024-03-08 01:59:45 -0600 | Rating Details | |
| 2024-03-08 00:36:55 -0600 | Rating Details |